GT Biopharma (GTBP) had the highest return between 2008 and 2013 by a US stock, returning 131,749,985%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2008-2013	131,749,985%
Sequans Communications (SQNS)	2008-2013	2,409,538.55%
QXO (QXO)	2008-2013	1,045,277.78%
Nutex Health (NUTX)	2008-2013	749,900.2%
Castellum (CTM)	2008-2013	469,465.22%
Ferguson (FERG)	2008-2013	429,884.04%
Metalla Royalty & Streaming (MTA)	2008-2013	302,585.71%
Pioneer Power Solutions (PPSI)	2008-2013	20,520.38%
Weatherford International (WFRD)	2008-2013	10,400%
Future Fintech (FTFT)	2008-2013	6,900%
Actinium Pharmaceuticals (ATNM)	2008-2013	5,254.54%
Par Pacific (PARR)	2008-2013	3,616.67%
Altisource Portfolio Solutions (ASPS)	2008-2013	2,945.05%
Nova Lifestyle I (NVFY)	2008-2013	2,906.67%
Clearfield (CLFD)	2008-2013	2,462.03%
Oxley Bridge Acquisition Limited Class A Ordinary Shares (OBA)	2008-2013	2,223.9%
eGain (EGAN)	2008-2013	2,175.56%
Virtus Investment Partners (VRTS)	2008-2013	2,122.78%
LifeMD (LFMD)	2008-2013	2,066.67%
Aris Mining (ARMN)	2008-2013	1,740.12%
3D Systems (DDD)	2008-2013	1,712.67%
Onity (ONIT)	2008-2013	1,567.52%
Mitek Systems (MITK)	2008-2013	1,463.16%
Predictive Oncology (POAI)	2008-2013	1,381.48%
Where Food Comes From (WFCF)	2008-2013	1,328.6%